Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4006 | 1864 | 43.9 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
707 | 2 | MATRIX METALLOPROTEINASE//METALLOPROTEINASES//MT1 MMP | 12920 |
4006 | 1 | MATRIX METALLOPROTEINASE//METALLOPROTEINASES//MORPHOL ESTOMATOL PHYSIOL | 1864 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MATRIX METALLOPROTEINASE | authKW | 479881 | 25% | 6% | 461 |
2 | METALLOPROTEINASES | authKW | 314365 | 12% | 9% | 224 |
3 | MORPHOL ESTOMATOL PHYSIOL | address | 193936 | 2% | 39% | 30 |
4 | HERITAGE MED 4 62 | address | 117926 | 1% | 60% | 12 |
5 | TISSUE INHIBITOR OF METALLOPROTEINASE | authKW | 105813 | 3% | 12% | 56 |
6 | REMODELING | authKW | 66500 | 7% | 3% | 138 |
7 | MATRIX METALLOPROTEINASE 9 | authKW | 63949 | 4% | 6% | 69 |
8 | EXTRACELLULAR MATRIX | authKW | 52775 | 11% | 2% | 196 |
9 | MATRIX METALLOPROTEINASE 2 | authKW | 49217 | 2% | 7% | 46 |
10 | S PEDIAT ONCOHEMATOL IMMUNOL | address | 49140 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 18527 | 39% | 0% | 733 |
2 | Peripheral Vascular Diseases | 15292 | 27% | 0% | 500 |
3 | Hematology | 791 | 7% | 0% | 131 |
4 | Medical Laboratory Technology | 788 | 4% | 0% | 68 |
5 | Medicine, Research & Experimental | 681 | 8% | 0% | 153 |
6 | Physiology | 542 | 7% | 0% | 127 |
7 | Cell Biology | 476 | 10% | 0% | 188 |
8 | Pharmacology & Pharmacy | 193 | 9% | 0% | 160 |
9 | Pathology | 100 | 3% | 0% | 52 |
10 | Endocrinology & Metabolism | 56 | 3% | 0% | 64 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MORPHOL ESTOMATOL PHYSIOL | 193936 | 2% | 39% | 30 |
2 | HERITAGE MED 4 62 | 117926 | 1% | 60% | 12 |
3 | S PEDIAT ONCOHEMATOL IMMUNOL | 49140 | 0% | 100% | 3 |
4 | DENT RIBEIRAO PRETO | 45933 | 3% | 6% | 48 |
5 | L99ES11 | 43677 | 0% | 67% | 4 |
6 | MED IPB HSL | 36853 | 0% | 75% | 3 |
7 | MAZANKOWSKI ALBERTA HEART | 27843 | 1% | 7% | 26 |
8 | CARDIOVASC TRANSLAT | 25880 | 0% | 23% | 7 |
9 | PHYSIOPATHOL CLIN BIOCHEM | 25587 | 0% | 31% | 5 |
10 | PHARM BIOCHEMINFIBIOC | 21839 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 5859 | 3% | 1% | 52 |
2 | CIRCULATION | 5596 | 5% | 0% | 92 |
3 | CARDIOVASCULAR RESEARCH | 4962 | 3% | 1% | 49 |
4 | ATHEROSCLEROSIS | 3940 | 3% | 0% | 51 |
5 | JOURNAL OF CARDIAC FAILURE | 3797 | 1% | 1% | 20 |
6 | CIRCULATION RESEARCH | 3366 | 2% | 0% | 46 |
7 | JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 3037 | 2% | 1% | 35 |
8 | AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2844 | 3% | 0% | 47 |
9 | EUROPEAN JOURNAL OF HEART FAILURE | 2220 | 1% | 1% | 18 |
10 | HEART FAILURE REVIEWS | 1945 | 0% | 1% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SPINALE, FG , (2007) MYOCARDIAL MATRIX REMODELING AND THE MATRIX METALLOPROTEINASES: INFLUENCE ON CARDIAC FORM AND FUNCTION.PHYSIOLOGICAL REVIEWS. VOL. 87. ISSUE 4. P. 1285-1342 | 154 | 31% | 508 |
2 | MITTAL, B , MISHRA, A , SRIVASTAVA, A , KUMAR, S , GARG, N , (2014) MATRIX METALLOPROTEINASES IN CORONARY ARTERY DISEASE.ADVANCES IN CLINICAL CHEMISTRY, VOL 64. VOL. 64. ISSUE . P. 1 -72 | 149 | 45% | 8 |
3 | HUGHES, BG , SCHULZ, R , (2014) TARGETING MMP-2 TO TREAT ISCHEMIC HEART INJURY.BASIC RESEARCH IN CARDIOLOGY. VOL. 109. ISSUE 4. P. - | 76 | 64% | 15 |
4 | FONTANA, V , SILVA, PS , GERLACH, RF , TANUS-SANTOS, JE , (2012) CIRCULATING MATRIX METALLOPROTEINASES AND THEIR INHIBITORS IN HYPERTENSION.CLINICA CHIMICA ACTA. VOL. 413. ISSUE 7-8. P. 656-662 | 72 | 72% | 24 |
5 | BACK, M , KETELHUTH, DFJ , AGEWALL, S , (2010) MATRIX METALLOPROTEINASES IN ATHEROTHROMBOSIS.PROGRESS IN CARDIOVASCULAR DISEASES. VOL. 52. ISSUE 5. P. 410-428 | 104 | 46% | 84 |
6 | AZEVEDO, A , PRADO, AF , ANTONIO, RC , ISSA, JP , GERLACH, RF , (2014) MATRIX METALLOPROTEINASES ARE INVOLVED IN CARDIOVASCULAR DISEASES.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. VOL. 115. ISSUE 4. P. 301 -314 | 94 | 50% | 8 |
7 | JANSSENS, S , LIJNEN, HR , (2006) WHAT HAS BEEN LEARNED ABOUT THE CARDIOVASCULAR EFFECTS OF MATRIX METALLOPROTEINASES FROM MOUSE MODELS?.CARDIOVASCULAR RESEARCH. VOL. 69. ISSUE 3. P. 585 -594 | 69 | 75% | 44 |
8 | RUDDY, JM , IKONOMIDIS, JS , JONES, JA , (2016) MULTIDIMENSIONAL CONTRIBUTION OF MATRIX METALLOPROTEINASES TO ATHEROSCLEROTIC PLAQUE VULNERABILITY: MULTIPLE MECHANISMS OF INHIBITION TO PROMOTE STABILITY.JOURNAL OF VASCULAR RESEARCH. VOL. 53. ISSUE 1-2. P. 1 -16 | 88 | 48% | 0 |
9 | PAPAGEORGIOU, N , TOUSOULIS, D , HATZIS, G , BRIASOULIS, A , ANDROULAKIS, E , GIOLIS, A , SIASOS, G , LATSIOS, G , VOGIATZI, G , TENTOLOURIS, C , ET AL (2012) GENETIC VARIABILITY OF MATRIX METALLOPROTEINASE GENES IN CARDIOVASCULAR DISEASE.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 10. P. 1206-1213 | 65 | 69% | 2 |
10 | SUNDSTROM, J , VASAN, RS , (2006) CIRCULATING BIOMARKERS OF EXTRACELLULAR MATRIX REMODELING AND RISK OF ATHEROSCLEROTIC EVENTS.CURRENT OPINION IN LIPIDOLOGY. VOL. 17. ISSUE 1. P. 45-53 | 71 | 61% | 58 |
Classes with closest relation at Level 1 |